The presenter does a really excellent job of explaining the value and power of ChatGPT's collaborative editing feature, called Canvas. He also has a creatively bizarre filming set with a pool table, a ...

"I think every astronomer is going to find something of value here, as NASA's missions enable the world to answer fundamental questions about how the universe got its start, and how it changed to ...

Insiders were net buyers of Vertex, Inc.'s ( NASDAQ:VERX ) stock during the past year. That is, insiders bought ...

The industry-first partner program is now available in India and enables Google Cloud and Oracle partners to purchase Oracle ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

AI Agent Security, which is built on Veza’s Access Graph, offers unified visibility into AI agents across leading platforms and allows security teams to answer critical questions such as “What AI ...

It's a good idea to go against the current market sentiment on this one. Vertex Pharmaceuticals continues to generate most of its revenue from its cystic fibrosis (CF) franchise. The company's ...

Physics and Python stuff. Most of the videos here are either adapted from class lectures or solving physics problems. I really like to use numerical calculations without all the fancy programming ...

Vertex has begun a full-court press for Journavx, enlisting NBA All-Star Jayson Tatum to discuss his use of the new non-opioid painkiller while recovering from a serious injury. Tatum ruptured his ...

Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.

Days after Inc42 reported Kiwi securing INR 208.5 Cr (around $24 Mn) in its Series B funding round led by Vertex Ventures, the startup has now confirmed the development. In a statement, the startup ...

Eli Lilly appears to be a great stock to buy on recent, unexpected weakness. Summit is an up-and-coming drugmaker that could be about to hit its stride. Vertex Pharmaceuticals' recent sell-off ...